PHR Long Call Strategy

PHR (Phreesia, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NYSE.

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking.

PHR (Phreesia, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $622.4M, a trailing P/E of 66.83, a beta of 0.88 versus the broader market, a 52-week range of 7.77-32.76, average daily share volume of 1.9M, a public-listing history dating back to 2019, approximately 2K full-time employees. These structural characteristics shape how PHR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.88 places PHR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 66.83 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a long call on PHR?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current PHR snapshot

As of June 30, 2026, spot at $10.36, ATM IV 33.10%, IV rank 6.18%, expected move 9.49%. The long call on PHR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long call structure on PHR specifically: PHR IV at 33.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a PHR long call, with a market-implied 1-standard-deviation move of approximately 9.49% (roughly $0.98 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PHR expiries trade a higher absolute premium for lower per-day decay. Position sizing on PHR should anchor to the underlying notional of $10.36 per share and to the trader's directional view on PHR stock.

PHR long call setup

The PHR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PHR near $10.36, the first option leg uses a $10.36 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PHR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PHR shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$10.36N/A

PHR long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

PHR long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on PHR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on PHR

Long calls on PHR express a bullish thesis with defined risk; traders use them ahead of PHR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

PHR thesis for this long call

The market-implied 1-standard-deviation range for PHR extends from approximately $9.38 on the downside to $11.34 on the upside. A PHR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current PHR IV rank near 6.18% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PHR at 33.10%. As a Healthcare name, PHR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PHR-specific events.

PHR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PHR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PHR alongside the broader basket even when PHR-specific fundamentals are unchanged. Long-premium structures like a long call on PHR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PHR chain quotes before placing a trade.

Frequently asked questions

What is a long call on PHR?
A long call on PHR is the long call strategy applied to PHR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With PHR stock trading near $10.36, the strikes shown on this page are snapped to the nearest listed PHR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PHR long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the PHR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 33.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PHR long call?
The breakeven for the PHR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PHR market-implied 1-standard-deviation expected move is approximately 9.49%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on PHR?
Long calls on PHR express a bullish thesis with defined risk; traders use them ahead of PHR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current PHR implied volatility affect this long call?
PHR ATM IV is at 33.10% with IV rank near 6.18%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related PHR analysis